Cargando…
Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo
The extreme aggressiveness and lethality of many cancer types appeal to the problem of the development of new-generation treatment strategies based on smart materials with a mechanism of action that differs from standard treatment approaches. The targeted delivery of nanoparticles to specific cancer...
Autores principales: | Kovalenko, Vera L., Komedchikova, Elena N., Sogomonyan, Anna S., Tereshina, Ekaterina D., Kolesnikova, Olga A., Mirkasymov, Aziz B., Iureva, Anna M., Zvyagin, Andrei V., Nikitin, Petr I., Shipunova, Victoria O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862264/ https://www.ncbi.nlm.nih.gov/pubmed/36678721 http://dx.doi.org/10.3390/pharmaceutics15010092 |
Ejemplares similares
-
Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells
por: Komedchikova, Elena N., et al.
Publicado: (2022) -
Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers’ Performance In Vitro and In Vivo
por: Shipunova, Victoria O., et al.
Publicado: (2021) -
Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents
por: Kovalenko, Vera L., et al.
Publicado: (2023) -
Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo
por: Obozina, Anastasiia S., et al.
Publicado: (2023) -
Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy
por: Shipunova, Victoria O., et al.
Publicado: (2023)